Medicine
Symproic 0.2 mg tablet
Symproic 0.2 mg tablet is a prescription medicine containing Naldemedine for oral use, marketed by BioDelivery Sciences International, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store SYMPROIC in a light resistant container at 20°C to 25°C (68°F to 77°F)…
Key facts
- Active ingredient (INN)
- Naldemedine
- Brand
- Symproic
- Strength
- 0.2 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets
- Marketing authorisation holder
- BioDelivery Sciences International
- Manufacturer
- BioDelivery Sciences International
- Origin register
- US FDA, United States
- Storage
- Store SYMPROIC in a light resistant container at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A06AH05 Naldemedine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 June 2019
- Identifiers
- RxCUI 1876603, 1876609DailyMed set ID b1a1256c-a1eb-4abe-ab1e-30e4711afd16NDC 59385-041Application NDA208854
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle, plastic | 59385-041-30 | BioDelivery Sciences International | 14 June 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Naldemedine is an opioid antagonist indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment, among other approved uses. MedsAcross supplies Naldemedine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NaldemedineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- SYMPROIC prescribing information (BioDelivery Sciences International) · U.S. National Library of Medicine, DailyMed
- Rizmoic: European public assessment report (EPAR) · European Medicines Agency
Need Symproic 0.2 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.